Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
advisor, advisory, affirmed, assumption, BioSense, borrowing, CCPA, comprising, confirmatory, constantly, consummate, conveyed, de, dissolution, distinct, distraction, double, earned, entry, falsifying, formatted, headcount, Hong, incremental, Kong, Macau, Nasdaq, Oppenheimer, outset, percentage, question, reconsider, remanded, remote, Republic, REXN, Singapore, standalone, streamlining, Taiwan, Territory, tiered, treble, unaudited, unchanged, underwriter, unpaid, upfront, verify, vi, writing, XBRL
Removed:
affiliate, afinitor, albumin, American, appeal, assumed, Baltimore, base, Benaim, billion, bringing, circumstance, compensatory, Conjugate, consecutive, construction, converted, cycle, daily, Ely, equivalent, eventual, Foundation, Grove, Guide, Heum, incentive, intrinsic, involved, Jeong, leading, leasehold, lessor, Lisa, minimize, Nanoparticle, nature, Nolan, NYSE, Ohio, payroll, Peter, platform, principle, ratio, renewed, rental, RNN, Road, select, Shady, Society, Suite, supersede, Suzdak, Tae, UMB, University, voted, week, weekly
Filing tables
Filing exhibits
OCUP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-218285) and Form S-8 (File No. 333-189240, 333-129294 and 333-217627) of Rexahn Pharmaceuticals, Inc., of our report dated February 21, 2020, relating to the financial statements of Rexahn Pharmaceuticals, Inc. which appear in this Annual Report on Form 10- K for the year ended December 31, 2019.
/s/ BAKER TILLY VIRCHOW KRAUSE, LLP |
Lancaster, Pennsylvania |
February 21, 2020 |